NextGen Healthcare Management
Management criteria checks 3/4
NextGen Healthcare's CEO is David Sides, appointed in Sep 2021, has a tenure of 2.17 years. total yearly compensation is $7.90M, comprised of 9% salary and 91% bonuses, including company stock and options. directly owns 0.91% of the company’s shares, worth $14.65M. The average tenure of the management team and the board of directors is 5.5 years and 6.3 years respectively.
Key information
David Sides
Chief executive officer
US$7.9m
Total compensation
| CEO salary percentage | 9.0% |
| CEO tenure | 2.2yrs |
| CEO ownership | 0.9% |
| Management average tenure | 5.5yrs |
| Board average tenure | 6.3yrs |
Recent management updates
Recent updates
Is There An Opportunity With NextGen Healthcare, Inc.'s (NASDAQ:NXGN) 49% Undervaluation?
Aug 24
NextGen Healthcare, Inc. Just Recorded A 16% EPS Beat: Here's What Analysts Are Forecasting Next
Jul 27Investors Will Want NextGen Healthcare's (NASDAQ:NXGN) Growth In ROCE To Persist
Jul 13We Think NextGen Healthcare (NASDAQ:NXGN) Can Manage Its Debt With Ease
Jun 08Calculating The Fair Value Of NextGen Healthcare, Inc. (NASDAQ:NXGN)
May 19What Does NextGen Healthcare, Inc.'s (NASDAQ:NXGN) Share Price Indicate?
Mar 14We Think NextGen Healthcare (NASDAQ:NXGN) Can Manage Its Debt With Ease
Feb 27Is NextGen Healthcare, Inc. (NASDAQ:NXGN) Expensive For A Reason? A Look At Its Intrinsic Value
Dec 08These Return Metrics Don't Make NextGen Healthcare (NASDAQ:NXGN) Look Too Strong
Oct 27At US$17.85, Is It Time To Put NextGen Healthcare, Inc. (NASDAQ:NXGN) On Your Watch List?
Sep 30NextGen Enterprise solution to be used by NY-based health center
Sep 28NextGen Healthcare, Inc.'s (NASDAQ:NXGN) Intrinsic Value Is Potentially 75% Above Its Share Price
Sep 07NextGen Healthcare (NASDAQ:NXGN) Is Finding It Tricky To Allocate Its Capital
Jul 29NextGen Healthcare Non-GAAP EPS of $0.16 in-line, revenue of $153.3M in-line, 2023 revenue outlook below estimates
Jul 26Is It Too Late To Consider Buying NextGen Healthcare, Inc. (NASDAQ:NXGN)?
May 17NextGen At A Crossroads
Oct 13Is There An Opportunity With NextGen Healthcare, Inc.'s (NASDAQ:NXGN) 44% Undervaluation?
Jun 29NextGen Healthcare shares fall despite Q4 earnings beat, FY forecast
May 27The Returns On Capital At NextGen Healthcare (NASDAQ:NXGN) Don't Inspire Confidence
May 23CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2023 | n/a | n/a | -US$6m |
| Jun 30 2023 | n/a | n/a | US$2m |
| Mar 31 2023 | US$8m | US$709k | -US$3m |
| Dec 31 2022 | n/a | n/a | US$23m |
| Sep 30 2022 | n/a | n/a | US$20m |
| Jun 30 2022 | n/a | n/a | -US$82k |
| Mar 31 2022 | US$16m | US$356k | US$2m |
Compensation vs Market: David's total compensation ($USD7.90M) is above average for companies of similar size in the US market ($USD5.11M).
Compensation vs Earnings: David's compensation has been consistent with company performance over the past year.
CEO
David Sides (52 yo)
2.2yrs
Tenure
US$7,895,821
Compensation
Mr. David William Sides serves as Chief Executive Officer and President at NextGen Healthcare, Inc. since September 22, 2021 and serves as its Director since October 13, 2021. He had been Chief Operating O...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 2.2yrs | US$7.90m | 0.91% $ 14.7m | |
| Executive VP & CFO | 7.7yrs | US$3.63m | 0.78% $ 12.5m | |
| Executive VP | 5.9yrs | US$1.63m | 0.14% $ 2.3m | |
| Executive Vice President of Commercial Growth | 1.8yrs | US$1.86m | 0.086% $ 1.4m | |
| Executive VP and Chief Growth & Strategy Officer | 1.3yrs | US$3.29m | 0.54% $ 8.7m | |
| Senior VP | 6.8yrs | no data | 0.066% $ 1.1m | |
| Chief Technology Officer | less than a year | no data | no data | |
| Chief Information & Security Officer | 10yrs | no data | no data | |
| Senior Vice President of Marketing | 5.2yrs | no data | no data | |
| Executive Vice President of Human Resources | 5.9yrs | no data | 0.12% $ 1.9m | |
| Executive Vice President of Enterprise | 7.3yrs | no data | no data | |
| Chief Medical Officer | 1.9yrs | no data | no data |
5.5yrs
Average Tenure
59.5yo
Average Age
Experienced Management: NXGN's management team is seasoned and experienced (5.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 2.1yrs | US$7.90m | 0.91% $ 14.7m | |
| Independent Chairman | 9.5yrs | US$335.01k | 0.22% $ 3.6m | |
| Independent Director | 10.8yrs | US$272.00k | 0.15% $ 2.4m | |
| Independent Director | 2.1yrs | US$260.00k | 0.046% $ 742.8k | |
| Independent Director | 6.3yrs | US$272.50k | 0.10% $ 1.7m | |
| Independent Director | 15.2yrs | US$285.00k | 0.12% $ 2.0m | |
| Independent Vice Chairman | 14.2yrs | US$295.77k | 0.10% $ 1.6m | |
| Independent Director | 2.1yrs | US$265.00k | 0.046% $ 742.8k | |
| Independent Director | 2.3yrs | US$262.50k | 0.049% $ 787.1k |
6.3yrs
Average Tenure
60yo
Average Age
Experienced Board: NXGN's board of directors are considered experienced (6.3 years average tenure).